Interplay between inflammation, immune system and neuronal pathways: Effect on gastrointestinal motility

World Journal of Gastroenterology

Volumn 16, Issue 44, 2010, Pages 5523-5535

  De Winter, Benedicte Y ^a   De Man, Joris G ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Afferent; Ileus; Inflammation; Mast cells; Neuroimmunomodulation; Neurons; Nitric oxide; Oxidative stress; Prostaglandins; Residential macrophages; Sepsis

Indexed keywords

6 [N (2 CHLORO 4 FLUOROPHENYL)SULFAMOYL] 1 CYCLOHEXENE 1 CARBOXYLIC ACID ETHYL ESTER; ALOSETRON; ANTIINFLAMMATORY AGENT; AR R17779; CAPSAICIN; CELECOXIB; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DICLOFENAC; DOBUTAMINE; DOPAMINE; DROTRECOGIN; ENDOCANNABINOID; FEDOTOZINE; GHRELIN; GHRELIN RECEPTOR AGONIST; HEXAMETHONIUM; IMMUNOMODULATING AGENT; IPAMORELIN; KETOTIFEN; LIPOPOLYSACCHARIDE; NICOTINE; NORADRENALIN; PLACEBO; SUPEROXIDE DISMUTASE; TACHYKININ RECEPTOR AGONIST; TEGASEROD; TZP 101; TZP 102; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL THERAPY; ANTIOXIDANT ACTIVITY; BACTERIAL INFECTION; CELL TYPE; CENTRAL NERVOUS SYSTEM; CLINICAL STUDY; CLINICAL TRIAL; DIGESTIVE SYSTEM FUNCTION DISORDER; DIGESTIVE SYSTEM INFLAMMATION; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; DRUG SELECTIVITY; DRUG TARGETING; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EDITORIAL; ENTERITIS; EXPERIMENTAL MODEL; EXPERIMENTAL STUDY; FLUID THERAPY; GASTROINTESTINAL INFECTION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL PAIN; GASTROINTESTINAL TRACT FUNCTION; GLIA CELL; HUMAN; ILEUS; IMMUNE SYSTEM; IMMUNOMODULATION; INFECTION PREVENTION; INFLAMMATION; INFLAMMATORY DISEASE; INFLAMMATORY MEDIATED ILEUS; INTRACELLULAR SIGNALING; IRRITABLE COLON; MACROPHAGE; MAST CELL; MOLECULAR INTERACTION; MULTIPLE ORGAN FAILURE; NERVE CELL; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOGENESIS; PERFUSION; PERITONITIS; RESUSCITATION; SENSORY NERVE CONDUCTION; SEPSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SPAIN; SPINAL CORD; TOXICITY; UNSPECIFIED SIDE EFFECT; VAGUS NERVE STIMULATION;

EID: 78649694961     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i44.5523     Document Type: Editorial

References (132)

1. Bochud PY, Calandra T. Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 2003; 326: 262-266
2. Ihle BU. Clinical practice guidelines for improving outcomes in sepsis. Heart Lung Circ 2008; 17 Suppl 4: S26-S31
3. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327
4. Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004; 30: 589-596
5. Brun-Buisson C, Meshaka P, Pinton P, Vallet B. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004; 30: 580-588
6. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554
7. Blanco J, Muriel-Bombín A, Sagredo V, Taboada F, Gandía F, Tamayo L, Collado J, García-Labattut A, Carriedo D, Valledor M, De Frutos M, López MJ, Caballero A, Guerra J, Alvarez B, Mayo A, Villar J. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008; 12: R158
8. Esper AM, Martin GS. Extending international sepsis epidemiology: the impact of organ dysfunction. Crit Care 2009; 13: 120
9. Cinel I, Dellinger RP. Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 2007; 20: 345-352
10. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-150
11. Sriskandan S, Altmann DM. The immunology of sepsis. J Pathol 2008; 214: 211-223
12. Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA. Post-injury multiple organ failure: the role of the gut. Shock 2001; 15: 1-10
13. Bauer AJ, Schwarz NT, Moore BA, Türler A, Kalff JC. Ileus in critical illness: mechanisms and management. Curr Opin Crit Care 2002; 8: 152-157
14. Livingston EH, Passaro EP Jr. Postoperative ileus. Dig Dis Sci 1990; 35: 121-132
15. MacFie J, O'Boyle C, Mitchell CJ, Buckley PM, Johnstone D, Sudworth P. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999; 45: 223-228
16. Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery 2002; 131: 241-244
17. Glatzle J, Leutenegger CM, Mueller MH, Kreis ME, Raybould HE, Zittel TT. Mesenteric lymph collected during peritonitis or sepsis potently inhibits gastric motility in rats. J Gastrointest Surg 2004; 8: 645-652
18. Schultz MJ, van der Poll T. Animal and human models for sepsis. Ann Med 2002; 34: 573-581
19. Piper RD, Cook DJ, Bone RC, Sibbald WJ. Introducing Critical Appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med 1996; 24: 2059-2070
20. Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov 2005; 4: 854-865
21. Bauer AJ. Mentation on the immunological modulation of gastrointestinal motility. Neurogastroenterol Motil 2008; 20 Suppl 1: 81-90
22. Turner MM, Berry LJ. Inhibition of gastric emptying in mice by bacterial endotoxins. Am J Physiol 1963; 205: 1113-1116
23. De Winter BY, Bredenoord AJ, De Man JG, Moreels TG, Herman AG, Pelckmans PA. Effect of inhibition of inducible nitric oxide synthase and guanylyl cyclase on endotoxininduced delay in gastric emptying and intestinal transit in mice. Shock 2002; 18: 125-131
24. de Winter BY, van Nassauw L, de Man JG, de Jonge F, Bredenoord AJ, Seerden TC, Herman AG, Timmermans JP, Pelckmans PA. Role of oxidative stress in the pathogenesis of septic ileus in mice. Neurogastroenterol Motil 2005; 17: 251-261
25. De Winter BY, Bredenoord AJ, Van Nassauw L, De Man JG, De Schepper HU, Timmermans JP, Pelckmans PA. Involvement of afferent neurons in the pathogenesis of endotoxininduced ileus in mice: role of CGRP and TRPV1 receptors. Eur J Pharmacol 2009; 615: 177-184
26. De Winter BY, De Man JG, Seerden TC, Depoortere I, Herman AG, Peeters TL, Pelckmans PA. Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice. Neurogastroenterol Motil 2004; 16: 439-446
27. Wirthlin DJ, Cullen JJ, Spates ST, Conklin JL, Murray J, Caropreso DK, Ephgrave KS. Gastrointestinal transit during endotoxemia: the role of nitric oxide. J Surg Res 1996; 60: 307-311
28. Cullen JJ, Doty RC, Ephgrave KS, Hinkhouse MM, Broadhurst K. Changes in intestinal transit and absorption during endotoxemia are dose dependent. J Surg Res 1999; 81: 81-86
29. Cullen JJ, Mercer D, Hinkhouse M, Ephgrave KS, Conklin JL. Effects of endotoxin on regulation of intestinal smooth muscle nitric oxide synthase and intestinal transit. Surgery 1999; 125: 339-344
30. Hellström PM, al-Saffar A, Ljung T, Theodorsson E. Endotoxin actions on myoelectric activity, transit, and neuropeptides in the gut. Role of nitric oxide. Dig Dis Sci 1997; 42: 1640-1651
31. Calatayud S, Barrachina MD, García-Zaragozá E, Quintana E, Esplugues JV. Endotoxin inhibits gastric emptying in rats via a capsaicin-sensitive afferent pathway. Naunyn Schmiedebergs Arch Pharmacol 2001; 363: 276-280
32. Eskandari MK, Kalff JC, Billiar TR, Lee KK, Bauer AJ. LPSinduced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am J Physiol 1999; 277: G478-G486
33. Eskandari MK, Kalff JC, Billiar TR, Lee KK, Bauer AJ. Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity. Am J Physiol 1997; 273: G727-G734
34. Cullen JJ, Caropreso DK, Ephgrave KS. Effect of endotoxin on canine gastrointestinal motility and transit. J Surg Res 1995; 58: 90-95
35. Cullen JJ, Ephgrave KS, Caropreso DK. Gastrointestinal myoelectric activity during endotoxemia. Am J Surg 1996; 171: 596-599
36. Spates ST, Cullen JJ, Ephgrave KS, Hinkhouse MM. Effect of endotoxin on canine colonic motility and transit. J Gastrointest Surg 1998; 2: 391-398
37. Cullen JJ, Titler S, Ephgrave KS, Hinkhouse MM. Gastric emptying of liquids and postprandial pancreatobiliary secretion are temporarily impaired during endotoxemia. Dig Dis Sci 1999; 44: 2172-2177
38. King JN, Gerring EL. The action of low dose endotoxin on equine bowel motility. Equine Vet J 1991; 23: 11-17
39. Eades SC, Moore JN. Blockade of endotoxin-induced cecal hypoperfusion and ileus with an alpha 2 antagonist in horses. Am J Vet Res 1993; 54: 586-590
40. Boeckxstaens GE, de Jonge WJ. Neuroimmune mechanisms in postoperative ileus. Gut 2009; 58: 1300-1311
41. De Winter BY, Boeckxstaens GE, De Man JG, Moreels TG, Herman AG, Pelckmans PA. Effect of adrenergic and nitrergic blockade on experimental ileus in rats. Br J Pharmacol 1997; 120: 464-468
42. De Winter BY, Robberecht P, Boeckxstaens GE, De Man JG, Moreels TG, Herman AG, Pelckmans PA. Role of VIP1/PACAP receptors in postoperative ileus in rats. Br J Pharmacol 1998; 124: 1181-1186
43. Torihashi S, Ozaki H, Hori M, Kita M, Ohota S, Karaki H. Resident macrophages activated by lipopolysaccharide suppress muscle tension and initiate inflammatory response in the gastrointestinal muscle layer. Histochem Cell Biol 2000; 113: 73-80
44. De Winter BY, Bredenoord AJ, De Man JG, Herman AG, Pelckmans PA. Effect of NS 2028, a guanylyl cyclase inhibitor, on septic ileus in mice. Gastroenterology 2002; 122: A555
45. De Filippis D, Iuvone T, Esposito G, Steardo L, Arnold GH, Paul AP, De Man Joris G, De Winter Benedicte Y. Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress. J Pineal Res 2008; 44: 45-51
46. Quintana E, Hernández C, Moran AP, Esplugues JV, Barrachina MD. Transcriptional up-regulation of nNOS in the dorsal vagal complex during low endotoxemia. Life Sci 2005; 77: 1044-1054
47. Quintana E, Hernández C, Alvarez-Barrientos A, Esplugues JV, Barrachina MD. Synthesis of nitric oxide in postganglionic myenteric neurons during endotoxemia: implications for gastric motor function in rats. FASEB J 2004; 18: 531-533
48. Overhaus M, Tögel S, Pezzone MA, Bauer AJ. Mechanisms of polymicrobial sepsis-induced ileus. Am J Physiol Gastrointest Liver Physiol 2004; 287: G685-G694
49. Schwarz NT, Kalff JC, Türler A, Engel BM, Watkins SC, Billiar TR, Bauer AJ. Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus. Gastroenterology 2001; 121: 1354-1371
50. De Winter BY, Boeckxstaens GE, De Man JG, Moreels TG, Herman AG, Pelckmans PA. Differential effect of indomethacin and ketorolac on postoperative ileus in rats. Eur J Pharmacol 1998; 344: 71-76
51. Korolkiewicz RP, Ujda M, Dabkowski J, Ruczyński J, Rekowski P, Petrusewicz J. Differential salutary effects of nonselective and selective COX-2 inhibitors in postoperative ileus in rats. J Surg Res 2003; 109: 161-169
52. Wattchow DA, De Fontgalland D, Bampton PA, Leach PL, McLaughlin K, Costa M. Clinical trial: the impact of cyclooxygenase inhibitors on gastrointestinal recovery after major surgery - a randomized double blind controlled trial of celecoxib or diclofenac vs. placebo. Aliment Pharmacol Ther 2009; 30: 987-998
53. Wang B, Glatzle J, Mueller MH, Kreis M, Enck P, Grundy D. Lipopolysaccharide-induced changes in mesenteric afferent sensitivity of rat jejunum in vitro: role of prostaglandins. Am J Physiol Gastrointest Liver Physiol 2005; 289: G254-G260
54. Smith PD, Ochsenbauer-Jambor C, Smythies LE. Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev 2005; 206: 149-159
55. Platt AM, Mowat AM. Mucosal macrophages and the regulation of immune responses in the intestine. Immunol Lett 2008; 119: 22-31
56. Zhang X, Mosser DM. Macrophage activation by endogenous danger signals. J Pathol 2008; 214: 161-178
57. de Jonge WJ, van den Wijngaard RM, The FO, ter Beek ML, Bennink RJ, Tytgat GN, Buijs RM, Reitsma PH, van Deventer SJ, Boeckxstaens GE. Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice. Gastroenterology 2003; 125: 1137-1147
58. Türler A, Kalff JC, Moore BA, Hoffman RA, Billiar TR, Simmons RL, Bauer AJ. Leukocyte-derived inducible nitric oxide synthase mediates murine postoperative ileus. Ann Surg 2006; 244: 220-229
59. Türler A, Schwarz NT, Türler E, Kalff JC, Bauer AJ. MCP-1 causes leukocyte recruitment and subsequently endotoxemic ileus in rat. Am J Physiol Gastrointest Liver Physiol 2002; 282: G145-G155
60. Hori M, Nobe H, Horiguchi K, Ozaki H. MCP-1 targeting inhibits muscularis macrophage recruitment and intestinal smooth muscle dysfunction in colonic inflammation. Am J Physiol Cell Physiol 2008; 294: C391-C401
61. Wehner S, Behrendt FF, Lyutenski BN, Lysson M, Bauer AJ, Hirner A, Kalff JC. Inhibition of macrophage function prevents intestinal inflammation and postoperative ileus in rodents. Gut 2007; 56: 176-185
62. Van Nassauw L, Adriaensen D, Timmermans JP. The bidirectional communication between neurons and mast cells within the gastrointestinal tract. Auton Neurosci 2007; 133: 91-103
63. Barbara G, Stanghellini V, De Giorgio R, Corinaldesi R. Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil 2006; 18: 6-17
64. Rijnierse A, Nijkamp FP, Kraneveld AD. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacol Ther 2007; 116: 207-235
65. de Jonge WJ, The FO, van der Coelen D, Bennink RJ, Reitsma PH, van Deventer SJ, van den Wijngaard RM, Boeckxstaens GE. Mast cell degranulation during abdominal surgery initiates postoperative ileus in mice. Gastroenterology 2004; 127: 535-545
66. The FO, Bennink RJ, Ankum WM, Buist MR, Busch OR, Gouma DJ, van der Heide S, van den Wijngaard RM, de Jonge WJ, Boeckxstaens GE. Intestinal handling-induced mast cell activation and inflammation in human postoperative ileus. Gut 2008; 57: 33-40
67. The FO, Buist MR, Lei A, Bennink RJ, Hofland J, van den Wijngaard RM, de Jonge WJ, Boeckxstaens GE. The role of mast cell stabilization in treatment of postoperative ileus: a pilot study. Am J Gastroenterol 2009; 104: 2257-2266
68. De Filippis D, Esposito G, Cipriano M, Scuderi C, De Man J, Iuvone T. Cannabidiol controls intestinal inflammation through modulation of enteric glial cells. International Cannabinoid Research Society. 19th symposium. 7-12 July, 2009, abstract 30
69. de Jonge WJ, Ulloa L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 2007; 151: 915-929
70. Liu CY, Mueller MH, Grundy D, Kreis ME. Vagal modulation of intestinal afferent sensitivity to systemic LPS in the rat. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1213-G1220
71. Mueller MH, Glatzle J, Kampitoglou D, Kasparek MS, Grundy D, Kreis ME. Differential sensitization of afferent neuronal pathways during postoperative ileus in the mouse jejunum. Ann Surg 2008; 247: 791-802
72. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 2009; 9: 418-428
73. Van Der Zanden EP, Boeckxstaens GE, de Jonge WJ. The vagus nerve as a modulator of intestinal inflammation. Neurogastroenterol Motil 2009; 21: 6-17
74. van der Zanden EP, Snoek SA, Heinsbroek SE, Stanisor OI, Verseijden C, Boeckxstaens GE, Peppelenbosch MP, Greaves DR, Gordon S, De Jonge WJ. Vagus nerve activity augments intestinal macrophage phagocytosis via nicotinic acetylcholine receptor alpha4beta2. Gastroenterology 2009; 137: 1029-1039, 1039.e1-e4
75. Costa M, Sanders KM, Schemann M, Smith TK, Cook IJ, de Giorgio R, Dent J, Grundy D, Shea-Donohue T, Tonini M, Brookes SJ. A teaching module on cellular control of small intestinal motility. Neurogastroenterol Motil 2005; 17 Suppl 3: 4-19
76. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-462
77. Song XM, Li JG, Wang YL, Hu ZF, Zhou Q, Du ZH, Jia BH. The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats. Shock 2008; 30: 468-472
78. Huston JM, Gallowitsch-Puerta M, Ochani M, Ochani K, Yuan R, Rosas-Ballina M, Ashok M, Goldstein RS, Chavan S, Pavlov VA, Metz CN, Yang H, Czura CJ, Wang H, Tracey KJ. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007; 35: 2762-2768
79. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM, Boeckxstaens GE. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005; 6: 844-851
80. The FO, Boeckxstaens GE, Snoek SA, Cash JL, Bennink R, Larosa GJ, van den Wijngaard RM, Greaves DR, de Jonge WJ. Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology 2007; 133: 1219-1228
81. Hamano N, Inada T, Iwata R, Asai T, Shingu K. The alpha2- adrenergic receptor antagonist yohimbine improves endotoxin- induced inhibition of gastrointestinal motility in mice. Br J Anaesth 2007; 98: 484-490
82. Vanneste G, Van Nassauw L, Kalfin R, Van Colen I, Elinck E, Van Crombruggen K, Timmermans JP, Lefebvre RA. Jejunal cholinergic, nitrergic, and soluble guanylate cyclase activity in postoperative ileus. Surgery 2008; 144: 410-426
83. Maher J, Johnson AC, Newman R, Mendez S, Hoffmann TJ, Foreman R, Greenwood-Van Meerveld B. Effect of spinal cord stimulation in a rodent model of post-operative ileus. Neurogastroenterol Motil 2009; 21: 672-677, e33-e34
84. Lomax AE, Sharkey KA, Furness JB. The participation of the sympathetic innervation of the gastrointestinal tract in disease states. Neurogastroenterol Motil 2010; 22: 7-18
85. Rühl A. Glial cells in the gut. Neurogastroenterol Motil 2005; 17: 777-790
86. Neunlist M, Van Landeghem L, Bourreille A, Savidge T. Neuro-glial crosstalk in inflammatory bowel disease. J Intern Med 2008; 263: 577-583
87. Bush TG, Savidge TC, Freeman TC, Cox HJ, Campbell EA, Mucke L, Johnson MH, Sofroniew MV. Fulminant jejunoileitis following ablation of enteric glia in adult transgenic mice. Cell 1998; 93: 189-201
88. Esposito G, Cirillo C, Sarnelli G, De Filippis D, D'Armiento FP, Rocco A, Nardone G, Petruzzelli R, Grosso M, Izzo P, Iuvone T, Cuomo R. Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease. Gastroenterology 2007; 133: 918-925
89. Cirillo C, Sarnelli G, Esposito G, Grosso M, Petruzzelli R, Izzo P, Calì G, D'Armiento FP, Rocco A, Nardone G, Iuvone T, Steardo L, Cuomo R. Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. Neurogastroenterol Motil 2009; 21: 1209-e112
90. Schmidt J, Stoffels B, Moore BA, Chanthaphavong RS, Mazie AR, Buchholz BM, Bauer AJ. Proinflammatory role of leukocyte-derived Egr-1 in the development of murine postoperative ileus. Gastroenterology 2008; 135: 926-936, 936.e1-e2
91. De Backer O, Elinck E, Priem E, Leybaert L, Lefebvre RA. Peroxisome proliferator-activated receptor gamma activation alleviates postoperative ileus in mice by inhibition of Egr-1 expression and its downstream target genes. J Pharmacol Exp Ther 2009; 331: 496-503
92. Moore BA, Türler A, Pezzone MA, Dyer K, Grandis J, Bauer AJ. Tyrphostin AG 126 inhibits development of postoperative ileus induced by surgical manipulation of murine colon. Am J Physiol Gastrointest Liver Physiol 2004; 286: G214-G224
93. Wehner S, Straesser S, Vilz TO, Pantelis D, Sielecki T, de la Cruz VF, Hirner A, Kalff JC. Inhibition of p38 mitogenactivated protein kinase pathway as prophylaxis of postoperative ileus in mice. Gastroenterology 2009; 136: 619-629
94. De Backer O, Elinck E, Blanckaert B, Leybaert L, Motterlini R, Lefebvre RA. Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress. Gut 2009; 58: 347-356
95. Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 2007; 109: 1574-1583
96. Buchholz BM, Chanthaphavong RS, Bauer AJ. Nonhemopoietic cell TLR4 signaling is critical in causing early lipopolysaccharide- induced ileus. J Immunol 2009; 183: 6744-6753
97. Buchholz BM, Bauer AJ. Membrane TLR signaling mechanisms in the gastrointestinal tract during sepsis. Neurogastroenterol Motil 2010; 22: 232-245
98. Buchholz BM, Billiar TR, Bauer AJ. Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus. Am J Physiol Gastrointest Liver Physiol 2010; 299: G531-G538
99. Kenny EF, O'Neill LA. Signalling adaptors used by Toll-like receptors: an update. Cytokine 2008; 43: 342-349
100. Kielian TL, Blecha F. CD14 and other recognition molecules for lipopolysaccharide: a review. Immunopharmacology 1995; 29: 187-205
101. Beutler B. Toll-like receptors: how they work and what they do. Curr Opin Hematol 2002; 9: 2-10
102. Akira S, Sato S. Toll-like receptors and their signaling mechanisms. Scand J Infect Dis 2003; 35: 555-562
103. Akira S, Yamamoto M, Takeda K. Role of adapters in Tolllike receptor signalling. Biochem Soc Trans 2003; 31: 637-642
104. Rumio C, Besusso D, Arnaboldi F, Palazzo M, Selleri S, Gariboldi S, Akira S, Uematsu S, Bignami P, Ceriani V, Ménard S, Balsari A. Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4. J Cell Physiol 2006; 208: 47-54
105. Barajon I, Serrao G, Arnaboldi F, Opizzi E, Ripamonti G, Balsari A, Rumio C. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem 2009; 57: 1013-1023
106. Hosoi T, Okuma Y, Matsuda T, Nomura Y. Novel pathway for LPS-induced afferent vagus nerve activation: possible role of nodose ganglion. Auton Neurosci 2005; 120: 104-107
107. Kuno M, Nemoto K, Ninomiya N, Inagaki E, Kubota M, Matsumoto T, Yokota H. The novel selective toll-like receptor 4 signal transduction inhibitor tak-242 prevents endotoxaemia in conscious Guinea-pigs. Clin Exp Pharmacol Physiol 2009; 36: 589-593
108. Russell JA. Management of sepsis. N Engl J Med 2006; 355: 1699-1713
109. Mackenzie I, Lever A. Management of sepsis. BMJ 2007; 335: 929-932
110. Holte K, Kehlet H. Postoperative ileus: a preventable event. Br J Surg 2000; 87: 1480-1493
111. Story SK, Chamberlain RS. A comprehensive review of evidence-based strategies to prevent and treat postoperative ileus. Dig Surg 2009; 26: 265-275
112. Mayer EA, Bradesi S, Chang L, Spiegel BM, Bueller JA, Naliboff BD. Functional GI disorders: from animal models to drug development. Gut 2008; 57: 384-404
113. Camilleri M, Chang L. Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. Gastroenterology 2008; 135: 1877-1891
114. Taub DD. Neuroendocrine interactions in the immune system. Cell Immunol 2008; 252: 1-6
115. Kraneveld AD, Rijnierse A, Nijkamp FP, Garssen J. Neuroimmune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets. Eur J Pharmacol 2008; 585: 361-374
116. Kiba T. Relationships between the autonomic nervous system, humoral factors and immune functions in the intestine. Digestion 2006; 74: 215-227
117. Ben-Horin S, Chowers Y. Neuroimmunology of the gut: physiology, pathology, and pharmacology. Curr Opin Pharmacol 2008; 8: 490-495
118. Taub DD. Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network. Vitam Horm 2008; 77: 325-346
119. De Smet B, Mitselos A, Depoortere I. Motilin and ghrelin as prokinetic drug targets. Pharmacol Ther 2009; 123: 207-223
120. Vila G, Maier C, Riedl M, Nowotny P, Ludvik B, Luger A, Clodi M. Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J Clin Endocrinol Metab 2007; 92: 3930-3934
121. Venkova K, Mann W, Nelson R, Greenwood-Van Meerveld B. Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus. J Pharmacol Exp Ther 2009; 329: 1110-1116
122. Popescu I, Fleshner PR, Pezzullo JC, Charlton PA, Kosutic G, Senagore AJ. The Ghrelin agonist TZP-101 for management of postoperative ileus after partial colectomy: a randomized, dose-ranging, placebo-controlled clinical trial. Dis Colon Rectum 2010; 53: 126-134
123. Wu R, Dong W, Qiang X, Wang H, Blau SA, Ravikumar TS, Wang P. Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats. Crit Care Med 2009; 37: 2421-2426
124. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114: 57-66
125. Moore BA, Peffer N, Pirone A, Bassiri A, Sague S, Palmer JM, Johnson DL, Nesspor T, Kliwinski C, Hornby PJ. GLP-2 receptor agonism ameliorates inflammation and gastrointestinal stasis in murine postoperative ileus. J Pharmacol Exp Ther 2010; 333: 574-583
126. Izzo AA, Sharkey KA. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 2010; 126: 21-38
127. Li YY, Li YN, Ni JB, Chen CJ, Lv S, Chai SY, Wu RH, Yüce B, Storr M. Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus. Neurogastroenterol Motil 2010; 22: 350-e88
128. de Filippis D, Iuvone T, d'amico A, Esposito G, Steardo L, Herman AG, Pelckmans PA, de Winter BY, de Man JG. Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase. Neurogastroenterol Motil 2008; 20: 919-927
129. Pantelis D, Kabba MS, Kirfel J, Kahl P, Wehner S, Buettner R, Hirner A, Kalff JC. Transient perioperative pharmacologic inhibition of muscularis macrophages as a target for prophylaxis of postoperative ileus does not affect anastomotic healing in mice. Surgery 2010; 148: 59-70
130. Wu WK, Cho CH. The pharmacological actions of nicotine on the gastrointestinal tract. J Pharmacol Sci 2004; 94: 348-358
131. Lubbers T, Buurman W, Luyer M. Controlling postoperative ileus by vagal activation. World J Gastroenterol 2010; 16: 1683-1687
132. Santos J, Alonso C, Guilarte M, Vicario M, Malagelada JR. Targeting mast cells in the treatment of functional gastrointestinal disorders. Curr Opin Pharmacol 2006; 6: 541-546